Live Q&A: Ulcerative Colitis in the 21st Century: Incorporating Guidelines and Real-World Evidence in Practice to Enhance Patient-Centered Care

Live Q&A: Ulcerative Colitis in the 21st Century: Incorporating Guidelines and Real-World Evidence in Practice to Enhance Patient-Centered Care is organized by CME Outfitters, LLC.

Premier Date: Wednesday, October 8, 2020
Credit Expiration Date: Thursday, October 8, 2021

Target Audience:
Gastroenterologists, PAs, nurse practitioners, and pharmacists

This activity offers CE credit for:
• Physicians (CME)
• Pharmacists (ACPE)
• Other

Statement of Need
Ulcerative colitis (UC) is a heterogeneous disorder that requires an individualized approach in order to achieve goals of treatment such as mucosal healing and deep, long-term remission. The American College of Gastroenterology (ACG) released updated treatment guidelines in 2019 that include recommendations for disease stratification, prognosis, treatment options, and disease monitoring. These guidelines, along with new efficacy, safety, and comparative effectiveness data and the approval of additional therapies, facilitate the identification of the right treatment for the right patient at the right time. Clinicians who care for patients with UC must ensure that they are aware of these updates and incorporate them into practice in order to optimize patient outcomes.

This live question and answer session is your opportunity to ask questions of our expert faculty. The original virtual symposium featured the UC guideline authors discussing the newest recommendations and their translation to practice. To view the full activity ahead of this live Q&A, click here.

Learning Objectives
At the end of this CE activity, participants should be able to:

• Follow the updated UC guidelines to incorporate elements of prognosis into diagnosis and treatment decision-making.
• Incorporate data on efficacy, safety, comparative effectiveness, and different routes of administration from clinical trials and real-world experience into treatment decision-making in moderate-to-severe UC.
• Implement strategies for improving patient-centered care and SDM in moderate-to-severe UC.

The following learning objectives pertain only to those requesting CNE or CPE credit:
• Identify the updated UC guidelines for diagnosis and treatment decision-making for patients with UC.
• Summarize data on efficacy, safety, comparative effectiveness, and different routes of administration from clinical trials and real-world experience for treatment decision-making in moderate-to-severe UC.
• Describe strategies for improving patient-centered care and SDM in moderate-to-severe UC.